Conatus has said it will have to cut around 40% of its workforce and jettison some pipeline projects after its Novartis-partnered non-alcoholic steatohepatitis (NASH) candidate failed a phase 2b ...

This Review details the epidemiological, mechanistic, clinical, biological and pathological features of nonalcoholic fatty liver disease—the liver manifestation of the metabolic syndrome that ...